Stockscreener 앱 받기
2.29
1.29%
-0.03
Gossamer Bio Inc 주식(GOSS)의 최신 뉴스
Gossamer Bio’s Stock Whipsaws As Biotech Investors Weigh Risk, Cash Runway And Pipeline Hopes - AD HOC NEWS
Brokers Offer Predictions for Gossamer Bio FY2030 Earnings - MarketBeat
Big Money Bets On Gossamer Bio (GOSS) As Institutional Ownership Hits 81 Percent - AOL.com
MB Generational Wealth LLC Buys Shares of 1,414,824 Gossamer Bio, Inc. $GOSS - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Trading Down 4.7%Here's What Happened - MarketBeat
Analysts Remain Bullish on Gossamer Bio (GOSS) Citing Undervaluation - Insider Monkey
11 Best Stocks Under $3 to Buy Right Now - Insider Monkey
Gossamer Bio Target of Unusually High Options Trading (NASDAQ:GOSS) - Defense World
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV), Gossamer Bio (GOSS) and Merck & Company (MRK) - The Globe and Mail
Gossamer Bio, Inc. (GOSS): Biotech Stock With A Promising 283% Upside Potential - DirectorsTalk Interviews
Traders Buy High Volume of Gossamer Bio Put Options (NASDAQ:GOSS) - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Shares Up 8.8%Should You Buy? - MarketBeat
Barclays Gives Gossamer Bio Overweight Rating and Bright Outlook - StocksToTrade
Gossamer Bio Sees Unusually Large Options Volume (NASDAQ:GOSS) - MarketBeat
Gossamer Bio (NASDAQ:GOSS): The High-Stakes Gamble Drawing Big Bank Interest - AOL.com
Is Gossamer Bio Inc forming a breakout pattern2025 Price Action Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
Gossamer Bio (NASDAQ:GOSS) Upgraded to "Strong-Buy" at Barclays - MarketBeat
Gossamer Bio (GOSS) Submits Mixed Securities Shelf Filing - GuruFocus
Barclays Initiates Coverage on Gossamer Bio With Overweight Rating, $9 Price Target - marketscreener.com
Barclays Initiates Coverage on Gossamer Bio (GOSS) with Overweig - GuruFocus
Institution Moves: Should I buy Gossamer Bio Inc stock nowTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Earnings Report: Is Gossamer Bio Inc a stock for growth or value investors2025 Performance Recap & Smart Swing Trading Alerts - baoquankhu1.vn
Gossamer Bio (NASDAQ:GOSS) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 5.7%Here's Why - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Gossamer Bio stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Gossamer Bio stock ahead of key trial By Investing.com - Investing.com India
Cantor Fitzgerald reiterates Overweight rating on Gossamer Bio stock - Investing.com
H.C. Wainwright reiterates Buy rating on Gossamer Bio stock ahead of key trial - Investing.com Nigeria
Gossamer Bio (NASDAQ:GOSS) Given Buy Rating at HC Wainwright - MarketBeat
GOSS: HC Wainwright & Co. Reiterates Buy Rating with $10 Price T - GuruFocus
With 63% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Gossamer Bio Inc Just Went Wild: Is This Tiny Biotech the Next Viral Moonshot or Total Trap? - AD HOC NEWS
Aug Spikes: How does Napco Security Technologies Inc score in quality rankingsTrade Volume Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Pullback Watch: What are the risks of holding ProShares Trust ProShares Short MSCI Emerging MarketsWeekly Market Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
What is the fair value of Gossamer Bio Inc. stock nowTrade Exit Summary & Smart Investment Allocation Tips - Улправда
Is Gossamer Bio Inc. stock trading at a premium valuation2025 Winners & Losers & High Accuracy Investment Signals - Улправда
Gossamer Bio, Inc. (GOSS): Analyst Ratings Highlight a Significant 294% Upside for Biotech Investors - DirectorsTalk Interviews
How Gossamer Bio Inc. (4GB) stock reacts to stronger dollarTrade Analysis Report & AI Powered Market Entry Ideas - Улправда
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Biotech Gossamer Bio gives new hires a stake with long-term stock options - Stock Titan
Can Gossamer Bio Inc. stock hit record highs againJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - Улправда
Gossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS) - Defense World
Gossamer Bio Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2024 -- Data Talk - 富途牛牛
1.12%
0.87%
자본화:
|
볼륨(24시간):